ENTX · Entera Bio Ltd
United States · RS rating 94 · As of 2026-11-03
| Price | 3.05 USD |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 94 / 91 / 80 / 56 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 52 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -100.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +22.2% |
| Market cap (USD) | $63.7M |